Dr. Dierk Niessing

•  12/2018: Care-for-Rare Science Award (shared with Dr. Tobias Hirsch)
  
  
•  Since 10/2017: Full Professor and Head of the Institute for Pharmaceutical Biotechnology at the Ulm University
  
  
•  Since 09/2016: Advisory committee member of patient registry for the PURA syndrome
  
  
•  Since 01/2016: Speaker of DFG Research Unit FOR2333
  
  
•  2016-2017: Elected Member of the
     Center for Advanced Studies (CAS) LMU
  
  
•  2015-2017: W2-Professor at the Medical Faculty of the LMU
  
  
•  2013: Habilitation in "Biochemistry" at the LMU
  
  
•  2010: Deputy Director of the Institute of Structural Biology
   
• 2009 Tenured Principal Investigator
  
  
• 2005-2009 Leader of Helmholtz-University-University
  Young Investigators Group
  
  
• 2003-2005 Postdoctoral Fellow at SGX-Parmarceuticals, Inc.
  San Diego, USA (Structural Biology, Biophysics)
  
  
• 2000-2002 Postdoctoral Fellow at The Rockefeller University
  New York, USA (Structural Biology, Biophysics)
  
  
• 1996-2000 PhD at the Max-Planck Institute for Biophysical Chemistry
  Göttingen, Germany (Developmental Biology, Genetics)
  
  
• 1990-1996 Studies at Faculty of Natural Sciences (Biology)
  Georgia Augusta University Göttingen, Germany